EMPAGEN M XR 5/1000MG TABLET

Empagen M XR 5/1000mg Tablet is a combination medication that contains two active ingredients: Empagliflozin & Metformin HCI in an extended-release formulation. Empagliflozin belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, while Metformin HCI is a biguanide medication. This combination is commonly used to treat type 2 diabetes mellitus, a condition characterized by high blood sugar levels.

Uses:

1. Type 2 diabetes mellitus: Empagen M XR 5/1000mg Tablet is prescribed to individuals with type 2 diabetes to help control blood sugar levels. It works by reducing the amount of glucose absorbed by the kidneys and increasing glucose excretion through urine (Empagliflozin), as well as by improving the body’s sensitivity to insulin and reducing glucose production in the liver (Metformin HCI).

Side Effects:

Like any medication, Empagen M XR 5/1000mg Tablet may cause side effects in some individuals. Common side effects can include:

• Urinary tract infections
• Genital yeast infections
• Increased urination
• Increased thirst
• Low blood sugar (hypoglycemia) when used in combination with other diabetes medications
• Nausea or vomiting
• Diarrhea
• Stomach discomfort
• Headache
• Dizziness

It is important to note that not all individuals will experience these side effects, and some may experience no side effects at all. If any side effects persist or worsen, it is recommended to consult a healthcare professional.

When Not to Use:

1. Type 1 diabetes: Empagen M XR 5/1000mg Tablet should not be used to treat individuals with type 1 diabetes, as it is not effective in managing this condition.
2. Diabetic ketoacidosis: It is contraindicated to use Empagen M XR 5/1000mg Tablet in individuals with diabetic ketoacidosis, a serious complication of diabetes characterized by high ketone levels in the blood.
3. Severe renal impairment: The use of Empagen M XR 5/1000mg Tablet is not recommended in individuals with severe kidney disease or with severely reduced kidney function.
4. Hypersensitivity: This medication should not be used in individuals with a known hypersensitivity or allergy to Empagliflozin, Metformin HCI, or any other ingredients present in the tablet.

Note: This is a general overview of the description, uses, side effects, and contraindications of Empagen M XR 5/1000mg Tablet (Empagliflozin & Metformin HCI Extended Release). It is crucial to consult with a healthcare professional or refer to the product’s packaging and instructions for specific and up-to-date information before using this medication for the management of type 2 diabetes.